Evaluation of a large-scale tuberculosis contact investigation in the Netherlands

European Respiratory Journal

Volumn 32, Issue 2, 2008, Pages 419-425

  Borgen, K ^a   Koster, B ^b   Meijer, H ^c   Kuyvenhoven, V ^d   Van Der Sandeand, M ^a   Cobelens, F ^d,e  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b Public Health Service of the city of Utrecht   (Netherlands)

^c Municipal Health Service (GGD)   (Netherlands)

^d KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Control; Efficiency; Public health; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; RADIOGRAPHY; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS; CONTACT EXAMINATION; DISEASE TRANSMISSION; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; METABOLISM; METHODOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 56149120659     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00136607     Document Type: Article

References (29)

1. Global Tuberculosis Control-Surveillance, Planning, Financing. WHO Report 2007 (WHO/HTM/TB/2007.376). Geneva, World Health Organization, 2007.
2. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002; 19: 765-775.
3. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49: 1-51.
4. Dasgupta K, Schwartzman K, Marchand R, Tennenbaum TN, Brassard P, Menzies D. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med 2000; 162: 2079-2086.
5. Etkind SC, Veen J. Contact follow-up in high- and low-prevalence countries. In: Reichman LB, Hershfield ES, eds. Tuberculosis: A Comprehensive International Approach. 2nd Edn. New York, Marcel Dekker Inc., 2000; pp. 377-396.
6. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000; 162: 2033-2038.
7. Reichler MR, Reves R, Bur S, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002; 287: 991-995.
8. Jereb J, Etkind SC, Joglar OT, Moore M, Taylor Z. Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999. Int J Tuberc Lung Dis 2003; 7: Suppl. 3, S384-S390.
9. National Tuberculosis Controllers Association, Centers for Disease Control and Prevention (CDC). Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep 2005; 54: 1-47.
10. Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung Dis 1992; 73: 73-76.
11. Kline SE, Hedemark LL, Davies SF. Outbreak of tuberculosis among regular patrons of a neighborhood bar. N Engl J Med 1995; 333: 222-227.
12. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99: 131-138.
13. Styblo K, Broekmans J, Borgdorff M. Expected decrease in the tuberculosis incidence during the elimination phase: how to determine its trend? Tuberculosis Surveillance and Research Unit report. Seoul, Royal Netherlands Tuberculosis Association, 1997.
14. Menzies D. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Clin Infect Dis 2000; 31: Suppl. 3, S71-S74.
15. Berkel GM, Cobelens FG, de Vries G, Draayer-Jansen IW, Borgdorff MW. Tuberculin skin test: estimation of positive and negative predictive values from routine data. Int J Tuberc Lung Dis 2005; 9: 310-316.
16. Comstock GW, Edwards LB, Philip RN, Winn WA. A comparison in the United States of America of two tuberculins, PPD-S and RT23. Bull World Health Organ 1964; 31: 161-170.
17. The WHO standard tuberculin test. WHO/TB/Technical Guide/3. Geneva, World Health Organization, 1963.
18. Lambregts-van Weezenbeek CS, Cobelens FG, Mensen EA, Commissie voor Praktische Tuberculosebestrijding. [The tuberculin skin test in the Netherlands: new policies for an old test; guideline from the Netherlands Tuberculosis Control Policy Committee]. Ned Tijdschr Geneeskd 2003; 147: 543-546.
19. van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409.
20. van Soolingen D, de Haas PEW, Kremer K. Restriction fragment length polymorphism typing of mycobacteria. In: Parish T, Stoker NG, eds. Mycobacterium Tuberculosis Protocols. Totowa, Humana Press Inc., 2001; pp. 165-203.
21. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, John Wiley & Sons, 1989.
22. Guld J, Bentzon MW, Bleiker MA, Griep WA, Magnusson M, Waaler H. Standardization of a new batch of purified tuberculin (PPD) intended for international use. Bull World Health Organ 1958; 19: 845-951.
23. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998; 88: 15-19.
24. Vynnycky E, Fine PE. Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol 2000; 152: 247-263.
25. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350: 2060-2067.
26. Hennekens CH, Buring JE. Epidemiology in Medicine. Philadelphia, Lippincott Williams & Wilkins, 1987; pp. 336-339.
27. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
28. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006; 174: 831-839.
29. Arend SM, Thijsen SF, Leyten EM, et al. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175: 618-627.